MK-2206 has been shown to be able to markedly reduce the CD34+/CD7−/CD4− T-ALL subset [36], which has been reported to be enriched in LICs, in addition leukemia-initiating cell activity has been shown to require Cn in T-ALL [15]. The gene discussed is CD34; the disease is acute lymphoblastic leukemia.